AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Codeifai Limited

0.004

-0.001-20.00%

Volume:1.51M

Turnover:6K

Market Cap:4.80M

PE:-0.28

High:0.005

Open:0.005

Low:0.004

Close:0.005

52wk High:0.017

52wk Low:0.004

Shares:1.20B

Float Shares:815.97M

Volume Ratio:0.21

T/O Rate:0.19%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.014

EPS(LYR):-0.014

ROE:-428.59%

ROA:-54.11%

PB:5.94

PE(LYR):-0.28

Loading ...

Overview Company News Filings

Codeifai - Requests Trading Halt Pending Capital Raising Announcement

THOMSON REUTERS

Rio Tinto PLC Stock (RIO) Moved Down by 3.13% on Jul 8: Drivers Behind the Movement

Gold Stocks Investors Are Buying For Lower Costs And Stronger Balance Sheets

Simply Wall St.

A Look At Coeur Mining (CDE) Valuation After Recent Share Price Pullback

Simply Wall St.

Marvell Technology, Flex Join S&P 500 in Reshuffling of More Than 20 Companies

MT Newswires Live

Assessing Coeur Mining (CDE) Valuation After Recent Share Price Weakness

Simply Wall St.

A Look At Coeur Mining (CDE) Valuation After Recent Share Price Volatility

Simply Wall St.

Kelun-Biotech Receives Investigational New Drug Approval from CDE for SKB118, a PD-1 x VEGF Bispecific Antibody

A Look At Coeur Mining (CDE) Valuation As Record Q1 Results And New Capital Returns Draw Focus

Simply Wall St.

Tianyu Pharma's Reflux Esophagitis API Clears CDE Review

MT Newswires Live

Codeifai Ltd-Update - Notification Regarding Unquoted Securities - Cde

THOMSON REUTERS

Codeifai Ltd-Director Change of Interest Notices X 2

THOMSON REUTERS

Is Coeur Mining’s New ESG Focus Quietly Reshaping Its Long‑Term Value Story (CDE)?

Simply Wall St.

Lynk Pharmaceuticals Announces NDA Acceptance for Zemprocitinib by NMPA

Codeifai Ltd-Appointment of Director

THOMSON REUTERS

A Look At Coeur Mining’s (CDE) Valuation After Recent Share Price Volatility

Simply Wall St.

Kelun-Biotech Receives IND Approval for SKB103, a Novel TAA-PD-L1 Bispecific ADC

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/CDE.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CDE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CDE.AU\",,,,,undefined,":{"symbol":"CDE.AU","market":"AU","secType":"STK","nameCN":"Codeifai Limited","latestPrice":0.004,"timestamp":1788156720000,"preClose":0.005,"halted":0,"volume":1509727,"delay":0,"changeRate":-0.2,"nameEN":"Codeifai Limited","floatShares":815965256,"shares":1199558639,"eps":-0.014039,"marketStatus":"Not Yet Opened","change":-0.001,"latestTime":"08-31 16:12:00 AEST","open":0.005,"high":0.005,"low":0.004,"amount":6041,"amplitude":0.2,"askPrice":0.005,"askSize":346235,"bidPrice":0.004,"bidSize":18583139,"shortable":3,"etf":0,"ttmEps":-0.014039,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.005,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":0.21413017741123747,"lotSize":0,"auctionPricing":{"symbol":"CDE.AU","preClose":0.005,"auctionPrice":0.005,"auctionVolume":1767,"auction":3,"marketStatus":"盘后竞价","timestamp":1788156000758}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CDE.AU\",,,,,undefined,":{"symbol":"CDE.AU","floatShares":815965256,"roa":"-54.11%","roe":"-428.59%","lyrEps":-0.014039,"volumeRatio":0.21413017741123747,"shares":1199558639,"dividePrice":0,"high":0.005,"amplitude":0.2,"preClose":0.005,"low":0.004,"week52Low":0.004,"pbRate":"5.94","psRate":"8.02","week52High":0.017,"institutionHeld":0,"latestPrice":0.004,"committee":0.963418,"eps":-0.014039,"divideRate":0,"volume":1509727,"delay":0,"ttmEps":-0.014039,"open":0.005,"prevYearClose":0.008,"prevWeekClose":0.005,"prevMonthClose":0.004,"prevQuarterClose":0.008,"fiveDayClose":0.005,"twentyDayClose":0.008,"sixtyDayClose":0.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CDE.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-05-19","symbol":"CDE.AU","defaultRemindTime":1747612800000,"type":"split","dateTimestamp":1747576800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CDE.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CDE.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652268445","title":"Codeifai - Requests Trading Halt Pending Capital Raising Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2652268445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652268445?lang=en_us&edition=fundamental","pubTime":"2026-07-20 07:44","pubTimestamp":1784504689,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260719:nFWN43J124:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CDE.AU","BK7050"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650222913","title":"Rio Tinto PLC Stock (RIO) Moved Down by 3.13% on Jul 8: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2650222913","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650222913?lang=en_us&edition=fundamental","pubTime":"2026-07-09 03:15","pubTimestamp":1783538110,"startTime":"0","endTime":"0","summary":"• Rio Tinto shares declined due to geopolitical tensions and falling global industrial metal prices.\n• Rising Treasury yields increased capital costs and prompted investor shifts away from mining equities.\n• Rio Tinto decided against operating the Sovereign Metals Kasiya rutile-graphite project in Malawi.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20240530/14da146101a6ee456de70058b6649b3d.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20240530/14da146101a6ee456de70058b6649b3d.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262018375-market-movers-rio-20260708","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1883866441.USD","LU1267930573.SGD","FCX","IE000M9KFDE8.USD","LU0708994859.HKD","LU0654597011.USD","BK7095","PICK","RIO","SIL","BK4015","IE00B19Z9P08.USD","GUNR","HL","LU2498475776.HKD","LU0345781412.USD","LU0300736492.USD","BK4210","GMET","BK7511","LU2272731782.SGD","HLXX","COPX","FBZ","SLX","CDE.AU","FCXG","SG9999002521.SGD","BK4017","SILJ","COPA","SLVP","LU2462611646.USD","GDXJ","LU0612318385.USD","LU1267930813.SGD","LU0266512473.USD","LU0788109121.HKD","CDE","LIT","LU0456854461.SGD","IE00B894F039.SGD","FLBR","SETM","RIO.AU","LU1992135472.HKD","SGDM","EART","IE00B7SZLL34.SGD","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645869827","title":"Gold Stocks Investors Are Buying For Lower Costs And Stronger Balance Sheets","url":"https://stock-news.laohu8.com/highlight/detail?id=2645869827","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645869827?lang=en_us&edition=fundamental","pubTime":"2026-06-24 10:29","pubTimestamp":1782268181,"startTime":"0","endTime":"0","summary":"Gold has re-emerged as a preferred refuge as investors react to softer growth signals from Europe and the UK, mixed data across Asia, and firm US yields tied to ongoing inflation concerns. With central banks and institutions seeking perceived safety, interest in high quality gold exposure has intensified. The Elite Gold Stocks screener focuses on gold miners with stronger balance sheets and lower production costs, which can be important when input costs and policy expectations are shifting...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice1-main-header/1585186555515","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice1-main-header/1585186555515"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-au/anglogold-ashanti/news/gold-stocks-investors-are-buying-for-lower-costs-and-stronge","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-au/anglogold-ashanti/news/gold-stocks-investors-are-buying-for-lower-costs-and-stronge","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GLDM","KGLD","JDST","IAU","GDXJ","IAUI","ISBC","BAR","GDXU","IGLD","GLDY","PHYS","AAAU","UGL","AEM.AU","JNUG","DULL","GDX","DGZ","CEF","USG","DZZ","SGDM","GBUG","UYM","GOAU","GLL","GOLI","DGP","RING","BGLD","BEGS","GOLY","IAUM","PICK","DBC","CDE","GDXY","FGDL","AU","DUST","GDXD","GLTR","OUNZ","SHNY","XME","AEM","GLD","SGOL","CDE.AU","BTGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642454056","title":"A Look At Coeur Mining (CDE) Valuation After Recent Share Price Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=2642454056","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642454056?lang=en_us&edition=fundamental","pubTime":"2026-06-09 12:38","pubTimestamp":1780979938,"startTime":"0","endTime":"0","summary":"How Coeur Mining stock has been trading\nCoeur Mining (CDE) has recently drawn attention after a mixed stretch of returns, with the stock up about 2% over the past day but down over the past week, month, and past 3 months.\nOver the past year, total return is just under 80%, while the past 3 years show a very large total return figure. That kind of volatility can matter if you are thinking about timing or position size around this gold and silver producer.\nSee our latest analysis for Coeur...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-cde/coeur-mining/news/a-look-at-coeur-mining-cde-valuation-after-recent-share-pric-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-cde/coeur-mining/news/a-look-at-coeur-mining-cde-valuation-after-recent-share-pric-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CDE","LU1223082196.USD","BK4017","LU1223083913.SGD","CDE.AU","LU1223082519.USD","BK7050"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641488017","title":"Marvell Technology, Flex Join S&P 500 in Reshuffling of More Than 20 Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2641488017","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641488017?lang=en_us&edition=fundamental","pubTime":"2026-06-08 17:58","pubTimestamp":1780912695,"startTime":"0","endTime":"0","summary":"Marvell Technology  and Flex   are set to join the S&P 500, effective June 22, S&P Dow Jones Indices said Friday.They will replace Campbell  and Pool , which will be added to the S&P SmallCap 600, the indexing and research firm said.Additionally, Roku , Coeur Mining , Semtech , Sanmina , and Viavi Solutions  will join the S&P MidCap 400, S&P said.Coty , Concentrix , Blackbaud , Credit Acceptance , Lazard , Eastern Bankshares , Wesbanco , Warby Parker , Liquidia , Rush Street Interactive , United States Lime & Minerals , and InvenTrust Properties  were also added to the S&P SmallCap 600, S&P said.Shares of Marvell and Flex were up 6.9% and 3.3%, respectively, in Monday's premarket activity.Roku shares were up 1.3% and Semtech 2.6%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CACC","CDE","RSPU","RSP",".SPX","LQDA","BLKB","SPYM","IVT.AU","SH","HIBS","MESmain","LAZ","VUG","CPB","ACWI","USLM","EBC","SCHB","VOOG","COTY","RSI","SANM","POOL","SPXU","UPRO","SPUU","SPYQ","SPXS","OEX","SMTC","TSPY","VTV","ROKU","VIAV","VYM","SCHG","WRBY","SFY","SPY","IJR","FLEX","NOBL","BMAY","CDE.AU","IVT","VOO","WSBC","MRVL","CNXC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638854175","title":"Assessing Coeur Mining (CDE) Valuation After Recent Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2638854175","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638854175?lang=en_us&edition=fundamental","pubTime":"2026-05-25 08:21","pubTimestamp":1779668496,"startTime":"0","endTime":"0","summary":"Coeur Mining (CDE) has come onto investors’ radar after recent share price swings, with the stock down about 9% over the past month and roughly 28% over the past 3 months.\nSee our latest analysis for Coeur Mining.\nAt a share price of US$17.63, Coeur Mining’s recent pullback, including a 1-day share price return of 1.12% decline and a 30-day share price return of 8.70% decline, contrasts with a very large 3-year total shareholder return. This suggests longer term momentum has been strong even...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-cde/coeur-mining/news/assessing-coeur-mining-cde-valuation-after-recent-share-pric","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-cde/coeur-mining/news/assessing-coeur-mining-cde-valuation-after-recent-share-pric","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4017","LU1223082196.USD","BK7050","LU1223082519.USD","LU1223083913.SGD","CDE","CDE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636090039","title":"A Look At Coeur Mining (CDE) Valuation After Recent Share Price Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2636090039","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636090039?lang=en_us&edition=fundamental","pubTime":"2026-05-17 23:43","pubTimestamp":1779032636,"startTime":"0","endTime":"0","summary":"Coeur Mining (CDE) has been drawing attention after recent share price pressure, with the stock down about 9% over the past day and 21% over the past 3 months. Investors are reassessing what the latest moves imply for the gold and silver producer’s valuation and risk profile.\nSee our latest analysis for Coeur Mining.\nDespite the recent 9.23% one day share price decline and a 21.45% fall over the past 90 days, Coeur Mining’s longer term picture looks very different. The company has a 1 year...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-cde/coeur-mining/news/a-look-at-coeur-mining-cde-valuation-after-recent-share-pric-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-cde/coeur-mining/news/a-look-at-coeur-mining-cde-valuation-after-recent-share-pric-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GBUG","XME","LU1223082519.USD","LU1223082196.USD","CEF","GOAU","BK4535","BEGS","BK4017","GLTR","LU1223083913.SGD","PICK","CDE.AU","BK7050","CDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635221989","title":"Kelun-Biotech Receives Investigational New Drug Approval from CDE for SKB118, a PD-1 x VEGF Bispecific Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2635221989","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635221989?lang=en_us&edition=fundamental","pubTime":"2026-05-13 08:00","pubTimestamp":1778630400,"startTime":"0","endTime":"0","summary":"CHENGDU, China, May 12, 2026 /PRNewswire/ --Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.  announced that it has received a clinical trial notice from the Center for Drug Evaluation  of the National Medical Products Administration  approving the Investigational New Drug  application for PD-1 x VEGF bispecific antibody SKB118  for the treatment of advanced solid tumors.In December 2025, Kelun-Biotech and Crescent Biopharma  entered into a strategic collaboration for SKB118/CR-001. Under the collaboration, Crescent granted Kelun-Biotech exclusive rights to research, develop, manufacture and commercialize SKB118/CR-001 in Greater China . In January 2026, Crescent announced the regulatory clearance of the IND application for SKB118/CR-001 by the U.S. Food and Drug Administration  to initiate its global ASCEND Phase I/II clinical trial  for the treatment of locally advanced or metastatic solid tumors. The trial is ongoing and expected to initially enroll up to 290 patients.","market":"us","thumbnail":"https://mma.prnewswire.com/media/2650617/logo_kelun_Biotech_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2650617/logo_kelun_Biotech_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/kelun-biotech-receives-investigational-new-drug-approval-from-cde-for-skb118-a-pd-1-x-vegf-bispecific-antibody-302769694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","LU1223082519.USD","BK4023","BK7050","BK4581","LU1223082196.USD","PD","BK7095","CDE","BK4585","LU1169590202.USD","XBI","CDE.AU","BK4588","BK4017","IND","IND.AU","LU1223083913.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634422524","title":"A Look At Coeur Mining (CDE) Valuation As Record Q1 Results And New Capital Returns Draw Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2634422524","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634422524?lang=en_us&edition=fundamental","pubTime":"2026-05-10 18:38","pubTimestamp":1778409513,"startTime":"0","endTime":"0","summary":"Coeur Mining (CDE) is back in focus after reporting record first quarter revenue of US$856.19 million and net income of US$246.76 million, supported by newly acquired New Gold mines and fresh capital return plans.\nSee our latest analysis for Coeur Mining.\nAt a share price of US$18.12, Coeur Mining has seen a 3.25% year to date share price return and a very large 3 year total shareholder return, helped by the New Gold acquisition, strong Q1 results and fresh capital return plans. However, the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-cde/coeur-mining/news/a-look-at-coeur-mining-cde-valuation-as-record-q1-results-an","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-cde/coeur-mining/news/a-look-at-coeur-mining-cde-valuation-as-record-q1-results-an","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7050","LU1223082519.USD","CDE","FCF","BK4535","LU1223083913.SGD","BK4017","CDE.AU","PICK","BK4211","LU1223082196.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633439898","title":"Tianyu Pharma's Reflux Esophagitis API Clears CDE Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2633439898","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633439898?lang=en_us&edition=fundamental","pubTime":"2026-05-08 17:17","pubTimestamp":1778231820,"startTime":"0","endTime":"0","summary":"Zhejiang Tianyu Pharmaceutical  unit Zhejiang Jingsheng Pharmaceutical's vonoprazan fumarate active pharmaceutical ingredient passed the technical review of the Center for Drug Evaluation  in China.Vonoprazan fumarate is used to treat reflux esophagitis, according to a Friday filing with the Shenzhen bourse.Shares of the pharmaceutical company closed 1% higher Friday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1223082519.USD","BK4017","OTX.SI","300702","BK6100","BK7050","LU1223083913.SGD","BK6520","BK0239","LU1223082196.USD","CDE","CDE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629079782","title":"Codeifai Ltd-Update - Notification Regarding Unquoted Securities - Cde","url":"https://stock-news.laohu8.com/highlight/detail?id=2629079782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629079782?lang=en_us&edition=fundamental","pubTime":"2026-04-23 07:14","pubTimestamp":1776899675,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUE1W28X3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CDE.AU","BK7050"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629704699","title":"Codeifai Ltd-Director Change of Interest Notices X 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2629704699","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629704699?lang=en_us&edition=fundamental","pubTime":"2026-04-21 13:02","pubTimestamp":1776747721,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUE6KZJ9H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CDE.AU","BK7050"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628521091","title":"Is Coeur Mining’s New ESG Focus Quietly Reshaping Its Long‑Term Value Story (CDE)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2628521091","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628521091?lang=en_us&edition=fundamental","pubTime":"2026-04-17 01:05","pubTimestamp":1776359157,"startTime":"0","endTime":"0","summary":"Coeur Mining recently released its 2025 Responsibility Report, outlining its approach to responsible mining and progress in areas such as water stewardship, safety performance, tailings management, and community engagement.\nA key insight from the report is the formal adoption of enterprise-wide water stewardship goals and advancement toward full tailings management conformance, signaling a deeper integration of ESG priorities into day-to-day operations.\nNext, we will explore how Coeur’s...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-cde/coeur-mining/news/is-coeur-minings-new-esg-focus-quietly-reshaping-its-longter","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-cde/coeur-mining/news/is-coeur-minings-new-esg-focus-quietly-reshaping-its-longter","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1223082519.USD","BK4017","BK7050","LU1223083913.SGD","LU1223082196.USD","CDE","ESG","CDE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626159983","title":"Lynk Pharmaceuticals Announces NDA Acceptance for Zemprocitinib by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2626159983","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626159983?lang=en_us&edition=fundamental","pubTime":"2026-04-10 08:00","pubTimestamp":1775779200,"startTime":"0","endTime":"0","summary":"SHANGHAI, HANGZHOU, China and BOSTON, April 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. , a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today announced that the New Drug Application  for its core product, zemprocitinib capsules, for the treatment of moderate-to-severe atopic dermatitis , has been formally accepted by the Center for Drug Evaluation  of the China National Medical Products Administration . This acceptance marks a critical milestone in the company's clinical development in inflammatory skin diseases and represents an important step toward Lynk Pharmaceuticals' transition to commercialization. Zemprocitinib capsules have the potential to provide a new treatment option for patients with atopic dermatitis.Preclinical and clinical studies have demonstrated that zemprocitinib potently and dose-dependently inhibits multiple JAK1-mediated inflammatory signaling pathways, supporting its therapeutic poten","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/lynk-pharmaceuticals-announces-nda-acceptance-for-zemprocitinib-by-nmpa-302738518.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","BK4202","LU1223082519.USD","RA","CDE.AU","LU1223082196.USD","CDE","ZK","BK4017","BK7050","BK4099","AD","LU1223083913.SGD","AS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626908137","title":"Codeifai Ltd-Appointment of Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2626908137","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626908137?lang=en_us&edition=fundamental","pubTime":"2026-04-09 13:07","pubTimestamp":1775711265,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nTUE3BZHXK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7050","CDE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625960381","title":"A Look At Coeur Mining’s (CDE) Valuation After Recent Share Price Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2625960381","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625960381?lang=en_us&edition=fundamental","pubTime":"2026-04-08 07:23","pubTimestamp":1775604235,"startTime":"0","endTime":"0","summary":"Why Coeur Mining is on investors’ radar today\nCoeur Mining (CDE) is drawing fresh attention after a recent move in its share price, with the stock gaining 2.2% over the past day but showing a 16.1% decline over the past month.\nSee our latest analysis for Coeur Mining.\nThat 2.2% 1 day share price gain comes after a 16.1% 30 day share price decline. Coeur Mining still carries an 8.3% year to date share price return and a very large 1 year total shareholder return of 295%. This suggests longer...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-cde/coeur-mining/news/a-look-at-coeur-minings-cde-valuation-after-recent-share-pri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-cde/coeur-mining/news/a-look-at-coeur-minings-cde-valuation-after-recent-share-pri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7050","LU1223082519.USD","CDE","LU1223083913.SGD","BK4017","CDE.AU","LU1223082196.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621068695","title":"Kelun-Biotech Receives IND Approval for SKB103, a Novel TAA-PD-L1 Bispecific ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2621068695","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621068695?lang=en_us&edition=fundamental","pubTime":"2026-03-24 17:24","pubTimestamp":1774344240,"startTime":"0","endTime":"0","summary":"CHENGDU, China, March 24, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.  today announced that the Investigational New Drug  application for SKB103, its self-developed novel bispecific antibody-drug conjugate with combined Tumor-Associated Antigen-targeting and Immuno-Oncology mechanisms , has been approved by the Center for Drug Evaluation  of the National Medical Products Administration  of China for the treatment of advanced solid tumors. The approval marks SKB103 as the Company's first TAA-PD-L1 bsADC candidate and its second bsADC program for tumor therapy to enter the clinical stage, following SKB571.Kelun-Biotech  is a holding subsidiary of Kelun Pharmaceutical , which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative biological drugs and small molecule drugs. Kelun-Biotech focuses on major disease areas such as solid tumors, autoimmune, and metabolic diseases, and in establishing a globalized drug development and","market":"nz","thumbnail":"https://mma.prnewswire.com/media/2650617/logo_kelun_Biotech_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2650617/logo_kelun_Biotech_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/kelun-biotech-receives-ind-approval-for-skb103-a-novel-taa-pd-l1-bispecific-adc-302723152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1979443071.USD","LU1169589451.USD","PD","LU1064130708.USD","BK0239","XBI","IND.AU","002422","ADC","IND","LU1223082519.USD","BK7050","BK0060","BK4080","BK4023","LU1169590202.USD","BK7095","LU1223082196.USD","LU1064131003.USD","LU1223083913.SGD","BK4231","CDE.AU","LU2148510915.USD","BK4585","BK4588","CDE","LU1934453819.USD","BK4581","BK4017"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":37,"code":"91000000","status":"200"}]}}